Drug manufacturer to complain over 'disgraceful' NICE secrecy
The manufacturer of an Alzheimer's drug has made a formal complaint to the NHS ombudsman accusing the National Institute for Health and Clinical Excellence of secrecy for refusing to make public the mathematical model it used in the decision to restrict use of the drug.
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
- 10 expert briefings every fortnight (Premium only)
Already a subscriber? Sign into your account here